Cited by 263Barrier Structure and Function StudiesAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Cerebrovascular Effects of Apolipoprotein E: Implications for Alzheimer Disease

Open access

Zlokovic, Berislav V.·2013·JAMA Neurology

DOI 10.1001/jamaneurol.2013.2152PMC PMC4414030

Open this paper in CoChat — free account

Abstract

Human apolipoprotein E (apoE) has 3 isoforms: apoE2, apoE3, and apoE4. APOE4 is a major genetic risk factor for Alzheimer disease and is associated with dementia in Down syndrome and poor neurological outcome after traumatic brain injury, cerebral hemorrhage, and other neuropathological disorders. While apoE4 can induce neuropathology by participating in various cellular and molecular pathways, herein I review data supporting the hypothesis that apoE4 has direct toxic effects on the cerebrovascular system that in turn can lead to secondary neuronal dysfunction and degeneration as well as accumulation of neurotoxins in brain such as β-amyloid (Aβ) in Alzheimer disease. I review Aβ-independent cerebrovascular effects of apoE, particularly activation of a proinflammatory cyclophilin A-mediated pathway in brain vascular pericytes by apoE4 that has recently been shown to lead to a loss of cerebrovascular integrity and blood-brain barrier breakdown causing neuronal injury. I also review Aβ-dependent cerebrovascular effects of apoE such as faulty Aβ clearance from brain to circulation by apoE4. Finally, I discuss isoform-specific interactions of apoE with low-density lipoprotein receptor-related protein 1 on brain vascular cells (ie, endothelial cells, pericytes), which play an important role in Aβ-independent and Aβ-dependent effects of apoE on cerebral vasculature.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2013.2152

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 4×
“factor B–MMP-9 pathway in pericytes via low-density lipoprotein receptor-related protein 1 (LRP1).(13) The study confirmed previous findings in cerebral vascular cells showing that apoE3 and apoE2 have a relatively high affinity for binding and/or interaction with LRP1; this is in contrast to apoE4, which shows weak i…”
Influential
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
Apolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 3×
“Several recent reviews provide an excellent overview on apoE isoform-specific toxic effects on neurons and effects on neuropathological disorders.(1,2,4) Therefore, the focus of the present review is on cerebrovascular effects of apoE.”
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 794

Flagged first, then by citations

Show all 19 references

Sorted by citations

Items 101–200 of 258

Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench
Wang, H., Zhang, C., Qiu, Y., Chen, A., Li, Y., & Hu, B. (2021) · Aging and Disease · doi:10.14336/ad.2021.0514 · Cited by 47
ApoE and cerebral insulin: Trafficking, receptors, and resistance
Rhea, E. M., Raber, J., & Banks, W. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104755 · Cited by 50
Energy and the Alzheimer brain
Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 47
Targeting Transferrin Receptor 1 for Enhancing Drug Delivery Through the Blood–Brain Barrier for Alzheimer’s Disease
Shen, X., Li, H., Zhang, B., Li, Y., & Zhu, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199793 · Cited by 45
Apolipoprotein E mimetic peptide, CN ‐105, improves outcomes in ischemic stroke
Tu, T. M., Kolls, B. J., Soderblom, E. J., Cantillana, V., Ferrell, P. D., Moseley, M. A., Wang, H., Dawson, H. N., & Laskowitz, D. T. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.399 · Cited by 45
Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort
Habes, M., Toledo, J. B., Resnick, S. M., Doshi, J., Van der Auwera, S., Erus, G., Janowitz, D., Hegenscheid, K., Homuth, G., Völzke, H., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4805 · Cited by 44
Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression
Shao, Y., Zhao, T., Zhang, W., He, J., Lu, F., Cai, Y., Lai, Z., Wei, N., Liang, C., Liu, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72616-0 · Cited by 43
Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment
Fiala, M., Terrando, N., & Dalli, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150367 · Cited by 43
Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid
Bastos, P. A. D., Ferreira, R. M., Manadas, B. J., Moreira, P. I., & Vitorino, R. M. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1299682 · Cited by 40
Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease
Kirchner, K., Garvert, L., Kühn, A. L., Bonk, S., Grabe, H. J., & der Auwera, S. V. (2023) · Cells · doi:10.3390/cells12212512 · Cited by 39
Pericytes for Therapeutic Approaches to Ischemic Stroke
Cao, L., Zhou, Y., Chen, M., Li, L., & Zhang, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.629297 · Cited by 41
The vascular contribution of apolipoprotein E to Alzheimer’s disease
Chen, F., Zhao, J., Meng, F., He, F., Ni, J., & Fu, Y. (2024) · Brain · doi:10.1093/brain/awae156 · Cited by 39
Apolipoprotein E, Carbon Dioxide Vasoreactivity, and Cognition in Older Adults: Effect of Hypertension
Hajjar, I., Sorond, F., & Lipsitz, L. A. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13235 · Cited by 37
ApoE-Deficient Promotes Blood–Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9
Zheng, M., Wei, J., Tang, Y., Yang, C., Wei, Y., Yin, X., & Liu, Q. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0291-x · Cited by 37
Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline
Nock, T. G., Chouinard‐Watkins, R., & Plourde, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.004 · Cited by 37
Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury
Cheng, X., Zheng, Y., Bu, P., Qi, X., Fan, C., Li, F., Kim, D., & Cao, Q. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.014 · Cited by 38
Microglia in Alzheimer's Disease: A Role for Ion Channels
Thei, L., Imm, J. L., Kaisis, E., Dallas, M. L., & Kerrigan, T. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00676 · Cited by 37
Autocrine Effects of Brain Endothelial Cell-Produced Human Apolipoprotein E on Metabolism and Inflammation in vitro
Marottoli, F. M., Trevino, T. N., Geng, X. H., Arbieva, Z. H., Kanabar, P. N., Maienschein‐Cline, M., Lee, J. C., Lutz, S. E., & Tai, L. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668296 · Cited by 38
Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease
Tamboli, I. Y., Heo, D., & Rebeck, G. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093120 · Cited by 35
Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury
Pan, H., Steixner-Kumar, A. A., Seelbach, A., Deutsch, N. R., Ronnenberg, A., Tapken, D., von Ahsen, N., Mitjans, M., Worthmann, H., Trippe, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0672-1 · Cited by 36
The apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging
Roussotte, F. F., Gutman, B. A., Madsen, S. K., Colby, J. B., Narr, K. L., & Thompson, P. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.030 · Cited by 37
Relation between plasma and brain lipids
Wellington, C. L., & Frikke-Schmidt, R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000291 · Cited by 33
Neurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 33
The anti-aging effect of velvet antler polypeptide is dependent on modulation of the gut microbiota and regulation of the PPARα/APOE4 pathway
Liu, X., Yang, Q., Li, H., Lan, X., Kan, M., Lin, J., Wang, J., Zhang, Z., Ming, S., Li, Z., et al. (2021) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2003061 · Cited by 32
Serum apolipoprotein E is associated with long-term risk of Alzheimer’s disease: The Rotterdam Study
Wolters, F. J., Koudstaal, P. J., Hofman, A., Duijn, C. M. V., & Ikram, M. A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.018 · Cited by 31
ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.
McFall, G. P., Wiebe, S. A., Vergote, D., Westaway, D. A., Jhamandas, J. H., Bäckman, L., & Dixon, R. A. (2014) · Neuropsychology · doi:10.1037/neu0000150 · Cited by 32
Differential effects of apoE4 and activation of ABCA1 on brain and plasma lipoproteins
Boehm-Cagan, A., Bar, R., Harats, D., Shaish, A., Levkovitz, H., Bielicki, J. K., Johansson, J. O., & Michaelson, D. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166195 · Cited by 29
Human apolipoprotein E as a reservoir of cryptic bioactive peptides: The case of ApoE 133‐167
Zanfardino, A., Bosso, A., Gallo, G., Pistorio, V., Napoli, M. D., Gaglione, R., Dell’Olmo, E., Varcamonti, M., Notomista, E., Arciello, A., et al. (2018) · Journal of Peptide Science · doi:10.1002/psc.3095 · Cited by 29
Advances in Modeling Alzheimer's Disease In Vitro
Sharma, N. S., Karan, A., Lee, D.-H., Yan, Z., & Xie, J. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100097 · Cited by 31
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081605 · Cited by 28
GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
Hu, L., Yao, W., Wang, F., Xia, R., & Peng, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090553 · Cited by 28
Cerebral Vascular Leak in a Mouse Model of Amyloid Neuropathology
Tanifum, E. A., Starosolski, Z. A., Fowler, S. W., Jankowsky, J. L., & Annapragada, A. V. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.125 · Cited by 28
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment
Zawar, I., Quigg, M., Johnson, E. L., Ghosal, S., Manning, C. A., & Kapur, J. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.0552 · Cited by 26
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Lozupone, M., Imbimbo, B. P., Balducci, C., Vecchio, F. L., Bisceglia, P., Latino, R. R., Leone, M. A., Dibello, V., Solfrizzi, V., Greco, A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12728 · Cited by 28
The Link Between Nutrition and Alzheimer’s Disease: From Prevention to Treatment
Martins, L. B., Silveira, A. L. M., & Teixeira, A. L. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0023 · Cited by 26
Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology
Mohamet, L. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.239 · Cited by 25
Unraveling the genes implicated in Alzheimer's disease
Giri, M., Shah, A., Upreti, B., & Rai, J. C. (2017) · Biomedical Reports · doi:10.3892/br.2017.927 · Cited by 25
Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
Zhang, W., Jiao, B., Zhou, M., Zhou, T., & Shen, L. H. (2016) · Stem Cells International · doi:10.1155/2016/7828049 · Cited by 26
The role of apolipoprotein E in neurodegeneration and cardiovascular disease
Lopez, M. F., Krastins, B., & Ning, M. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.901892 · Cited by 24
Influence of multiple APOE genetic variants on cognitive function in a cohort of older men – results from the Normative Aging Study
Prada, D., Colicino, E., Power, M. C., Cox, D. G., Weisskopf, M. G., Hou, L., Spiro, A., Vokonas, P., Zhong, J., Sánchez-Guerra, M., et al. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0223-x · Cited by 24
The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: an ‘Omics’ perspective
Tan, H., Gozal, D., & Gozal, D. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204640 · Cited by 24
Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
Skoog, I. G., Hörder, H., Frändin, K., Johansson, L. H., Östling, S., Blennow, K., Zetterberg, H., & Zettergren, A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00225 · Cited by 24
Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions
Wasseff, S. K., & Scherer, S. S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.018 · Cited by 24
Metformin alleviates the depression-like behaviors of elderly apoE4 mice via improving glucose metabolism and mitochondrial biogenesis
Lin, Y., Dai, X., Zhang, J., & Chen, X. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113772 · Cited by 23
Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes
Finan, G. M., Realubit, R. B., Chung, S., Lütjohann, D., Wang, N., Cirrito, J. R., Karan, C., & Kim, T. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.015 · Cited by 22
Kynurenines and other novel therapeutic strategies in the treatment of dementia
Majláth, Z., Tajti, J., & Vécsei, L. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613494989 · Cited by 23
Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems
Badimon, A., Torrente, D., & Norris, E. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087046 · Cited by 21
Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus
Roeben, B., the TREND study team, Maetzler, W., Vanmechelen, E., Schulte, C., Heinzel, S., Stellos, K., Godau, J., Huber, H., Brockmann, K., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150575 · Cited by 19
Associations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population
Wu, Z., Tao, Q., Chen, Y., Liu, Z., Sun, Y., Yang, P., Lu, S.-J., Xu, M., Yang, J., & Dong, Q. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s62554 · Cited by 23
Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
Shen, G., Hu, S. X., Zhao, Z., Zhang, L., & Ma, Q. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00251 · Cited by 20
Substances of abuse and the blood brain barrier: Interactions with physical exercise
Małkiewicz, M. A., Małecki, A., Toborek, M. J., Szarmach, A., & Winklewski, P. J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.026 · Cited by 21
Effect of aluminum combined with ApoEε4 on Tau phosphorylation and Aβ deposition
Wang, Y., Li, H., Zhang, J., Han, Y., Song, J., Wang, L., Hao, Y., He, C., Nie, J., Zhang, Q., et al. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126700 · Cited by 20
APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage
Hostettler, I. C., Seiffge, D. J., Wong, A., Ambler, G., Wilson, D., Shakeshaft, C., Banerjee, G., Sharma, N., Jäger, H. R., Cohen, H., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200851 · Cited by 20
Apolipoprotein E genotype and physical function among older people with mild cognitive impairment
Doi, T., Shimada, H., Makizako, H., Tsutsumimoto, K., Uemura, K., & Suzuki, T. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12291 · Cited by 20
Alzheimer Disease and Cellular Mechanisms of Memory Storage
Arshavsky, Y. I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000043 · Cited by 19
The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease
Valanti, E.-K., Chroni, A., & Sanoudou, D. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000615 · Cited by 20
APOE4, Age, and Sex Regulate Respiratory Plasticity Elicited by Acute Intermittent Hypercapnic-Hypoxia
Nair, J., Welch, J. F., Marciante, A. B., Hou, T., Lu, Q. L., Fox, E. J., & Mitchell, G. S. (2023) · Function · doi:10.1093/function/zqad026 · Cited by 18
Arterial Blood Pressure Variability and Other Vascular Factors Contribution to the Cognitive Decline in Parkinson’s Disease
Pierzchlińska, A., Kwaśniak-Butowska, M., Sławek, J. W., Droździk, M., & Białecka, M. A. (2021) · Molecules · doi:10.3390/molecules26061523 · Cited by 18
Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models
Li, T., Li, D., Wei, Q., Shi, M., Xiang, J., Gao, R., Chen, C., & Xu, Z. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106114 · Cited by 17
Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults
Tsiknia, A. A., Reas, E. T., Bangen, K. J., Sundermann, E. E., McEvoy, L. K., Brewer, J. B., Edland, S. D., Banks, S. J., & Initiative, A. D. N. (2022) · Brain Communications · doi:10.1093/braincomms/fcac035 · Cited by 17
Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice
East, B. S., Fleming, G., Peng, K., Olofsson, J., Levy, E., Mathews, P. M., & Wilson, D. A. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.009 · Cited by 20
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders
Libri, I., Silvestri, C., Caratozzolo, S., Alberici, A., Pilotto, A., Archetti, S., Trainini, L., Borroni, B., Padovani, A., & Benussi, A. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.04.003 · Cited by 16
Effects of Shenque Moxibustion on Behavioral Changes and Brain Oxidative State in Apolipoprotein E-Deficient Mice
Liu, J., Zhao, B., Cui, Y., Huang, Y., Huang, C., Huang, J., Han, L., & Lao, L. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/804804 · Cited by 16
APOE genotype, hypertension severity and outcomes after intracerebral haemorrhage
Biffi, A., Murphy, M. P., Kubiszewski, P. P., Kourkoulis, C. E., Schwab, K. M., Gurol, M. E., Greenberg, S. M., Viswanathan, A., Anderson, C. D., & Rosand, J. M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz018 · Cited by 17
Brain-targeted nanoparticles to overcome the blood-brain barrier
Seko, I., ŞAHİN, A., Tonbul, H., & Çapan, Y. (2020) · Journal of Pharmaceutical Technolgy · doi:10.37662/jpt.2020.4 · Cited by 16
HDL and Endothelial Function
Wu, Y., Xu, Y., Chen, J., Zhao, M., & Rye, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-1592-5_3 · Cited by 17
Breakdown of the blood–brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?
Frank, C. J., & McNay, E. C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13074 · Cited by 16
Genetic and environmental risk factors for dementia in African adults: A systematic review
Donkor, D. M., Marfo, E., Bockarie, A. S., Tettevi, E. J., Antwi, M. H., Dogah, J., Osei, G. N., & Simpong, D. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70220 · Cited by 15
Risk factors for amyloid positivity in older people reporting significant memory concern
Zhang, J., Zhou, W., Cassidy, R. M., Su, H., Su, Y., & Zhang, X. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.09.015 · Cited by 17
Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways
Auler, N., Tonner, H., Pfeiffer, N., & Grus, F. H. (2021) · Biology · doi:10.3390/biology10121296 · Cited by 15
Using Induced Pluripotent Stem Cells to Explore Genetic and Epigenetic Variation Associated With Alzheimer’S Disease
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
Huang, D., Liao, W., Li, J., Chen, T., Wang, X., Zhao, R., Zhang, L., Yu, X., Zheng, D., & Luan, P. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302015 · Cited by 15
Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood
Li, H., Zhu, H., Wallack, M., Mwamburi, M., Abdul‐Hay, S. O., Leissring, M. A., & Qiu, W. Q. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150428 · Cited by 14
APOE ɛ 4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke
Werden, E., Khlif, M. S., Bird, L., Cumming, T. B., Bradshaw, J., Khan, W., Pase, M. P., Restrepo, C., Veldsman, M., Egorova, N., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190566 · Cited by 15
Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
Abyadeh, M., Gupta, V., Paulo, J. A., Sheriff, S., Shadfar, S., Fitzhenry, M. J., Amirkhani, A., Gupta, V. B., Salekdeh, G. H., Haynes, P. A., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0312-1 · Cited by 15
Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study
Nishtala, A., Himali, J. J., Beiser, A., Murabito, J. M., Seshadri, S. S., Wolf, P. A., & Au, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141881 · Cited by 16
Behavioral and biologic characteristics of cancer-related cognitive impairment biotypes
Mulholland, M. M., Prinsloo, S., Kvale, E. A., Dula, A. N., Palesh, O. G., & Kesler, S. R. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-023-00774-6 · Cited by 13
Does metabolic failure at the synapse cause Alzheimer’s disease?
Engel, P. A. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.013 · Cited by 13
Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction
Zaldua, S., Damen, F. C., Pisharody, R., Thomas, R., Fan, K. D., Ekkurthi, G. K., Scheinman, S. B., Alahmadi, S., Marottoli, F. M., Alford, S. T., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03919 · Cited by 13
Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
Sakurai, R., Pieruccini‐Faria, F., Cornish, B. F., Fraser, J., Binns, M. A., Beaton, D., Dilliott, A. A., Kwan, D. T., Ramirez, J., Tan, B., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13740 · Cited by 12
Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide
Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12
Prospective associations of exercise and depressive symptoms in older adults: the role of apolipoprotein E4
Ku, P., Steptoe, A., & Chen, L. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1537-1 · Cited by 12
Cerebral microvascular changes in healthy carriers of the APOE-ɛ4 Alzheimer's disease risk gene
Aamand, R., Rasmussen, P. M., Andersen, K. S., de Paoli, S., Weitzberg, E., Christiansen, M., Lund, T. E., & Østergaard, L. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae369 · Cited by 11
The brain’s weakness in the face of trauma: How head trauma causes the destruction of the brain
Johnstone, D. M., Mitrofanis, J., & Stone, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1141568 · Cited by 11
A Destruction Model of the Vascular and Lymphatic Systems in the Emergence of Psychiatric Symptoms
Segawa, K., Blumenthal, Y., Yamawaki, Y., & Ohtsuki, G. (2021) · Biology · doi:10.3390/biology10010034 · Cited by 11
Apolipoprotein E receptor pathways in Alzheimer disease
Schmidt, V., Carlo, A.-S., & Willnow, T. E. (2014) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1262 · Cited by 10
Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Initiative, A. D. N., Wang, J., Peng, G., Liu, P., Tan, X., & Luo, B. (2019) · Cognitive Neurodynamics · doi:10.1007/s11571-019-09536-x · Cited by 10
Assessing Cognitive Improvement in People with Down Syndrome: Important Considerations for Drug-Efficacy Trials
Fernandez, F., & Reeves, R. H. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_12 · Cited by 11
The Role of APOE and NF-κB in Alzheimer’s Disease
Davies, D. A. (2021) · Immuno · doi:10.3390/immuno1040027 · Cited by 10
ApoE deficiency promotes colon inflammation and enhances the inflammatory potential of oxidized-LDL and TNF-α in primary colon epithelial cells
El‐Bahrawy, A. H., Tarhuni, A. F., Kim, H., Subramaniam, V., Benslimane, I., Elmageed, Z. Y. A., Okpechi, S. C., Ghonim, M. A., Hemeida, R. A. M., Abo‐Youssef, A. M., et al. (2016) · Bioscience Reports · doi:10.1042/bsr20160195 · Cited by 10
Effects of antimony on antioxidant system, damage indexes of blood-brain barrier and ultrastructure of zebrafish (Danio rerio)
Xu, K., Zou, H., Yang, A., Yao, Q., Li, Q., Zhang, J., & Hu, X. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.110013 · Cited by 9
Objective Physical Function in the Alzheimer’s Disease Continuum: Association with Cerebrospinal Fluid Biomarkers in the ALBION Study
Sampatakakis, S. N., Mamalaki, E., Ntanasi, E., Kalligerou, F., Liampas, I., Yannakoulia, M., Gargalionis, A. N., & Scarmeas, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814079 · Cited by 9
Association of Paraoxonase1 enzyme and its genetic single nucleotide polymorphisms with cardio-metabolic and neurodegenerative diseases
Jeelani, H., Tabassum, N., Afroze, D., & Rashid, F. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100775 · Cited by 9
The effects of the apoE4 genotype on the developing mouse retina
Maharshak, I., Salomon‐Zimri, S., Antes, R., Liraz, O., Nisgav, Y., Livnat, T., Weinberger, D., Colton, C. A., Solomon, A., & Michaelson, D. M. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.11.001 · Cited by 9
The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer’s Disease
Safieh, M., Liraz, O., Ovadia, M., & Michaelson, D. M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230514 · Cited by 8
Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women
Szoeke, C. E. I., Goodwill, A. M., Gorelik, A., Dennerstein, L., Caeyenberghs, K., Simpson, S., Hill, E., & Campbell, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180815 · Cited by 8
Perivascular space burden interacts with APOE-ε4 status on cognition in older adults
Gogniat, M. A., Khan, O. A., Bown, C. W., Liu, D., Pechman, K. R., Davis, L. T., Gifford, K. A., Landman, B. A., Hohman, T. J., & Jefferson, A. L. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.002 · Cited by 7
Modeling Mixed Vascular and Alzheimer’s Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice
Hayden, E. Y., Huang, J., Charreton, M., Nuñez, S., Putman, J. N., Teter, B., Lee, J. T., Welch, A. E., Frautschy, S. A., Cole, G. M., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00786-0 · Cited by 7
Endothelial Cell APOE3 Regulates Neurovascular, Neuronal, and Behavioral Function
Marottoli, F. M., Zhang, H., Flores-Barrera, E., de la Villarmois, E. A., Damen, F. C., Fernández, A. M. M. M., Blesson, H. V., Chaudhary, R., Nguyen, A. L., Nwokeji, A. E., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319816 · Cited by 7
Sex differences in cognition, anxiety-phenotype and therapeutic effect of metformin in the aged apoE-TR mice
Lin, Y., Luo, X., Wang, F., Cai, H., Lin, Y., Kang, D., & Fang, W. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00684-w · Cited by 7

Authors: Zlokovic, B. V.
Venue: JAMA Neurology
Publisher: American Medical Association (AMA)
Published: 2013-04-01
Volume: 70
Issue: 4
Pages: 440
ISSN: 2168-6149 (ISSN-L)
DOI: 10.1001/jamaneurol.2013.2152
PMC: PMC4414030
OpenAlex: W1994259160
Cited by: 263
References: 19
Citations by year: 2026: 9 · 2025: 15 · 2024: 13 · 2023: 15 · 2022: 17 · 2021: 21 · 2020: 14 · 2019: 17 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 30 · 2014: 42 · 2013: 5
FWCI: 18.90
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (NS34467)
National Institute on Aging (R01AG023084, R01AG039452, AG23084, R37AG023084, AG039452, RF1AG039452)
National Institute of Neurological Disorders and Stroke (R37NS034467, NS34467, R01NS034467)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: apolipoprotein E, APOE ε4, APOE isoforms, cerebrovascular dysfunction, Alzheimer's disease, amyloid-beta, blood-brain barrier disruption, cyclophilin A, vascular pericytes, neuroinflammation, amyloid clearance, LDL receptor-related protein 1, cerebral vasculature, Down syndrome, traumatic brain injury, cerebral hemorrhage
MeSH terms: Alzheimer Disease, Animals, Apolipoproteins E, Blood-Brain Barrier, Cerebrovascular Circulation, Humans, Amyloid beta-Peptides, NF-kappa B, Matrix Metalloproteinase 9, Cyclophilin A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cerebrovascular Effects of Apolipoprotein E: Implications for Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks